Press Releases
The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University (GW) School of Medicine and Health Sciences and member of the GW Cancer Center, to investigate HIV-1…
Recognized cancer prevention and control expert Elmer E. Huerta, MD, MPH, will serve as the director of the Cancer Preventorium at the George Washington University (GW) Cancer Center and as professor of medicine at the GW School of Medicine and Health Sciences.
Enrollment in a supportive oncodermatology program is associated with a significantly improved quality of life score, according to a recent survey from the George Washington University (GW) Cancer Center. The results of the survey were published in the Journal of Drugs in Dermatology.
GW dermatology experts are available to speak for media stories during Skin Cancer Awareness Month.
Researchers at the GW Cancer Center published a new knowledgebase and web portal, OncoMX, which will improve the exploration and research of cancer biomarkers in the context of related evidence.
WASHINGTON (January 22, 2020) - The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
WASHINGTON (Sept. 24, 2019) - PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.
WASHINGTON (Aug. 16, 2019) - The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.
Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University (GW) Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University (GW) and the GW Cancer Center today announced that Carla J. Berg, PhD, MBA, has been named the associate center director for population sciences and policy for the GW Cancer Center. Berg, who starts…